Methods for treating inflammatory and/or autoimmune symptoms associated with biologic and/or mrna vaccine administration
AssigneePkz, LLC
InventorsJ. Phillip Kennedy, Karyemaître Aliffe
Life of this patent
Estimating the term…
Abstract
Methods for treating inflammatory, autoinflammatory or autoimmune symptoms associated with administration of a biologic (e.g., a vaccine) are described herein. Certain methods include treating side effects of mRNA based vaccines such as COVID-19 vaccines.
Claims27
A method of treating or preventing an inflammatory, autoinflammatory and/or autoimmune symptom associated with administration of a biologic to a subject, the method comprising administering to the subject an effective amount of a composition containing an immunosuppressant, immunomodulator, anti-autoimmune, anti-allergy, anti-inflammatory agent, or a combination thereof.
A method of treating or preventing an inflammatory, autoinflammatory and/or autoimmune symptom associated with administration of COVID-19 vaccine to a subject, the method comprising administering to the subject an effective amount of a composition containing an immunosuppressant, immunomodulator, anti-autoimmune, anti-allergy, anti-inflammatory agent, or combinations thereof.
Use of an immunosuppressant, immunomodulator, anti-autoimmune, anti-allergy, anti-inflammatory agent, or a combination thereof, in the manufacture of a medicament for treating or preventing an inflammatory, autoinflammatory and/or autoimmune symptom associated with administration of a biologic to a subject.
Use of an immunosuppressant, immunomodulator, anti-autoimmune, anti-allergy, anti-inflammatory agent, or a combination thereof, in the manufacture of a medicament for treating or preventing an inflammatory, autoinflammatory and/or autoimmune symptom associated with administration of a COVID-19 vaccine to a subject.
Dependencies are inferred from the claim text.